IFIH1 and clinically amyopathic dermatomyositis: Based on this, we enrolled refractory CADM patients who tested positive for anti‐melanoma differentiation‐associated gene 5 (MDA5) antibodies and presented with rapidly progressive interstitial pneumonia unresponsive to combined immunosuppressive therapy.